CLINICAL TRIALS PROFILE FOR NATAMYCIN

All Clinical Trials for NATAMYCIN

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00516399 ↗	A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine	Terminated	Los Angeles Biomedical Research Institute	Phase 3	2008-03-01	The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
NCT00516399 ↗	A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine	Terminated	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 3	2008-03-01	The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
NCT00516399 ↗	A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine	Terminated	University of California, Los Angeles	Phase 3	2008-03-01	The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
NCT00557362 ↗	Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer	Completed	Aravind Eye Hospitals, India	Phase 1/Phase 2	2007-11-01	We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.
NCT00557362 ↗	Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer	Completed	Dartmouth-Hitchcock Medical Center	Phase 1/Phase 2	2007-11-01	We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.
NCT00557362 ↗	Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer	Completed	That Man May See, Inc.	Phase 1/Phase 2	2007-11-01	We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.

Clinical Trial Conditions for NATAMYCIN

Condition Name

Condition Name for NATAMYCIN
Intervention	Trials
Fungal Keratitis	4
Corneal Ulcer	3
Eye Infections, Fungal	2
Infection, Fungal	1

Condition MeSH

Condition MeSH for NATAMYCIN
Intervention	Trials
Keratitis	5
Corneal Ulcer	4
Ulcer	3
Mycoses	3

Clinical Trial Locations for NATAMYCIN

Trials by Country

Trials by Country for NATAMYCIN
Location	Trials
India	6
United States	4
Nepal	2

Trials by US State

Trials by US State for NATAMYCIN
Location	Trials
California	4

Clinical Trial Progress for NATAMYCIN

Clinical Trial Phase

Clinical Trial Phase for NATAMYCIN
Clinical Trial Phase	Trials
Phase 3	5
Phase 2/Phase 3	1
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for NATAMYCIN
Clinical Trial Phase	Trials
Completed	4
Not yet recruiting	1
Terminated	1

Clinical Trial Sponsors for NATAMYCIN

Sponsor Name

Sponsor Name for NATAMYCIN
Sponsor	Trials
Aravind Eye Hospitals, India	4
University of California, San Francisco	4
Dartmouth-Hitchcock Medical Center	3

Sponsor Type

Sponsor Type for NATAMYCIN
Sponsor	Trials
Other	22
NIH	3